Molsidomine in the treatment of patients with stable coronary artery disease

Mechanisms of action and clinical application of vasodilator molsidomine (direct nitric oxide donor) in patients with stable coronary heart disease are considered. Results of the clinical studies are discussed; the efficacy of use and place of molsidomine (Sydnopharm) in the treatment of patients with stable angina are evaluated.